Total revenue -- $128.6 million in the fiscal fourth quarter ended Dec. 31, 2025, with primary growth from DEFENCATH and the first full-quarter contribution from the Melinta portfolio. Fiscal 2026 ...
Good morning, and welcome to the CorMedix Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. Leading the call tod ...
LucidLink Corp., provider of a cloud network-attached storage system based on object storage technology, today is introducing ...
ARPA-H PROSPR program to support the development of TPN-101 to slow aging and help people stay healthy longerSAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Transposon Therapeutics, a biotechnology ...
2d
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
As announced, Jaguar received an up-front payment of $16M of non-dilutive capital in January 2026 upon entering U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results